  - Lilly negotiates drug-marketing partnership with Turkey's MN
Levent Selamoglu, CEO of MN Pharmaceuticals, said the company is in advanced discussion about co-marketing its products with Eli Lilly and Co. in 26 countries. The Turkish drugmaker's portfolio consists mostly of injectable therapies. MN has been approached by multinational firms for partnership since it secured an FDA license in 2006, Selamoglu said. Bloomberg Businessweek (10/3)        | John Jantsch invites you to go local
As customers continue to rely on the Web to help them screen local businesses, local businesses must take steps to ensure that they pop to the top of online searches. Duct Tape Marketing's John Jantsch offers strategies for local marketing success in this free white paper from American Express OPEN, How to Win at the Local Marketing Game. Download your free copy now, exclusively for SmartBrief readers. |
 - Experts create mouse model for autism
Researchers at Cold Spring Harbor Laboratory in New York created an animal model for autism by deleting a set of genes in mice, according to a study published in the Proceedings of the National Academy of Sciences. They hope the bioengineered mice could help shed light on the physiological basis for autism and help improve the diagnosis and treatment of the developmental disorder. Yahoo!/Agence France-Presse (10/3) - Key proteins play a role in cancer-diabetes link, study finds
Researchers at Harvard Medical School found that mice fed a high-fat diet were at lower risk of developing type 2 diabetes when they had high levels of the proteins Lin28a and Lin28b, which play a role in the risk of developing of some types of cancer. The results suggest a clear molecular pathway that affects diabetes and cancer, which may lead to the development of new medications designed to target the pathway and reduce the risk of developing the diseases, the researchers said in the journal Cell. EndocrineWeb.com (9/29)  | LET’S GO DESIGN: Episode #5
In this episode of SolidWorks’ interactive web series, Jeremy moves closer to the final design of our Hot Rod Baby Buggy and also hot-wires the golf cart motor to show how the aluminum tracks perform flawlessly. Watch at LetsGoDesign.tv. |
 - Complete Genomics, Scripps to map genomes of elderly people
Complete Genomics has partnered with the Scripps Health system to sequence 1,000 whole genomes of elderly people without any major conditions or complications to identify genes that play a role in longevity. The Wellderly Study will involve people between 80 and 108 and use Complete Genomics' sequencing service. Xconomy/San Francisco (10/3)  |  |  | | FREE TRIAL – Thomson Reuters Cortellis™ Pipeline Intelligence
Discover new opportunities in drug development and licensing faster. Cortellis gives you an innovative way of finding and acting on drug pipelines, deals, patents, companies, breaking industry news, and conference coverage in one source, intuitively presented.
Click here to see if you qualify for a free trial! | |  |  |  |
 | Global Developments |  |  | | - Paladin withdraws bid to acquire Afexa
Paladin Labs rescinded its hostile bid for Afexa Life Sciences, clearing the way for Valeant Pharmaceuticals International to complete an $88 million takeover of the Cold-FX maker. Paladin's decision came after Afexa agreed to increase a breakup fee payable to Valeant. "As a result of this agreement, a basic condition of Paladin's offer cannot be met and, therefore, no Afexa shares will be taken up when the offer expires on Oct. 7, 2011," according to a Paladin statement. Paladin is still expected to benefit from the Valeant deal because it owns at least $5 million worth of Afexa shares. Canadian Business/The Canadian Press (10/3) - Life Technologies may establish production facility in Scotland
California-based Life Technologies is considering setting up a manufacturing plant in Renfrewshire, Scotland, and might spend as much as $30 million on the facility. The California-based firm already has 500 workers at Inchinnan in Renfrewshire in which many are involved in making cell cultures for use in drug production. BBC (10/2)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| Industrial & Environmental | | | | - Toyota plans to market plant-based biofuel by 2020
Toyota Motor has developed a strain of yeast to make a plant-based biofuel, which the company plans to bring to market by 2020, business newspaper Nikkei reported. Toyota plans to spend the next four to five years to bring down the production cost of the biofuel, the report said. Reuters (10/3) | News from BIO | | | | - BIOtechNOW
BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This monthly e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the monthly BIOtechNOW e-newsletter.
| SmartQuote | | | |  | Procrastination is opportunity's assassin."
--Victor Kiam,
American businessman  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, October 03, 2011
- Friday, September 30, 2011
- Thursday, September 29, 2011
- Wednesday, September 28, 2011
- Tuesday, September 27, 2011
| | | Lead Editor: Adam Gaub
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment